SIGNATUREFD, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,732
+2.1%
1,171
-3.6%
0.00%0.0%
Q2 2023$43,825
+69.5%
1,215
+79.5%
0.00%0.0%
Q1 2023$25,855
-36.4%
677
-5.3%
0.00%0.0%
Q4 2022$40,684
+56.5%
715
+7.4%
0.00%0.0%
Q3 2022$26,000
-21.2%
666
-11.0%
0.00%0.0%
Q2 2022$33,000
+13.8%
748
+4.5%
0.00%0.0%
Q1 2022$29,000
+26.1%
716
+23.4%
0.00%0.0%
Q4 2021$23,000
+4.5%
580
+6.4%
0.00%0.0%
Q3 2021$22,000
-21.4%
545
-12.9%
0.00%0.0%
Q2 2021$28,000
+16.7%
626
+9.2%
0.00%0.0%
Q1 2021$24,000
+4.3%
573
+7.5%
0.00%0.0%
Q4 2020$23,000
+64.3%
5330.0%0.00%0.0%
Q3 2020$14,0000.0%533
+5.8%
0.00%0.0%
Q2 2020$14,000
+180.0%
504
+99.2%
0.00%
Q1 2020$5,000
+400.0%
253
+416.3%
0.00%
Q4 2019$1,0000.0%490.0%0.00%
Q3 2019$1,0000.0%490.0%0.00%
Q2 2019$1,000490.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders